ClearLake Labs Expands Third-Party Testing and QR Verification for Peptides in Canada, USA, and Costa Rica

Image: https://www.globalnewslines.com/uploads/2026/06/1780629299.jpg

New authentication system links batch-specific COAs to third-party laboratory results through QR-based verification.
Boise, Idaho, USA - June 5, 2026 - ClearLake Labs, a North American supplier of research peptides, today announced the continued expansion of its third-party testing and product verification framework aimed at improving documentation transparency and access to analytical testing data across its distribution network.

As demand for American Peptides, Canada Peptides, and Peptides in Costa Rica continues to grow within the research and laboratory supply sector, the company notes that customers are increasingly prioritizing product traceability, consistent sourcing information, and access to verifiable testing documentation.

To support these expectations, ClearLake Labs has implemented an enhanced verification process that incorporates third-party analytical testing through independent laboratory partners, including Chromate.org. Each Certificate of Analysis (COA) is now linked with a QR-based authentication system that allows customers to access batch-specific laboratory test data directly through digital scanning.

According to the company, the system is designed to improve the accessibility of testing information and provide an additional layer of documentation transparency for research customers reviewing product specifications and laboratory results.

"Independent testing and clear documentation access are becoming increasingly important within the research peptide industry," said a spokesperson for ClearLake Labs. "Our goal is to ensure customers can easily verify batch-level information supported by third-party laboratory analysis in a transparent and accessible format."

ClearLake Labs emphasizes that all products are strictly intended for laboratory and research purposes only and are not designed for human consumption, medical use, or therapeutic application.

In addition to its enhanced verification system, the company has expanded its regional fulfillment network to improve operational efficiency and reduce shipping delays across multiple regions, including the United States, Canada, and Costa Rica.

Current fulfillment locations include:

*
Idaho, USA - supporting distribution of American Peptides [https://clearlakelabs.com/]

*
Vancouver, Canada - supporting distribution of Canada Peptides [https://clearlakelabs.com/]

*
Tamarindo, Costa Rica - supporting distribution of Peptides in Costa Rica [https://clearlakelabs.com/]

The company states that this regional structure is intended to streamline logistics, minimize customs-related delays, and improve overall delivery efficiency for research customers in different markets.

ClearLake Labs also noted that it will continue investing in third-party testing standards, documentation systems, and fulfillment improvements throughout 2026 as the research supply and laboratory testing industry continues to evolve.

For more information, visit: https://www.clearlakelabs.com [https://www.clearlakelabs.com]

Independent laboratory verification available at: https://chromate.org [https://chromate.org]
Media Contact
Company Name: ClearLake Labs
Contact Person: Matt Lewis
Email: Send Email [http://www.universalpressrelease.com/?pr=clearlake-labs-expands-thirdparty-testing-and-qr-verification-for-peptides-in-canada-usa-and-costa-rica]
City: Boise
State: Idaho
Country: United States
Website: https://clearlakelabs.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.